1-7 of 7
Xiaojian Zhu
Close
Sort by
Journal Articles

Real-World Experience with Selinexor -Containing Regimens in Post-Transplant AML/MDS Patients Who MRD Still Positive after First-Line Preemptive Treatment

Xiwen Tong, Shuai Su, Bin Xu, Xiaojian Zhu, Yizhou Peng, Jin Jie, Xia Mao, Min Xiao, Jay Mei, Donghua Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5837.
https://doi.org/10.1182/blood-2023-186006
Published: 2023
Journal Articles

Efficacy and Safety of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Relapse/Refractory Non-Hodgkin Lymphoma: Real-World Data in Chinese Population

Zixun Yan, Dehui Zou, Yuhua Li, Xiaojian Zhu, Dongmei Ji, Wenbin Qian, Ying Lu, Chunyan Ji, Keshu Zhou, Hongmei Jing, Hua Yang, Lanfang Li, Fei Li, Kailin Xu, Ting Niu, Depei Wu, Yu Hu, Weili Zhao
Journal: Blood
Blood (2023) 142 (Supplement 1): 6928.
https://doi.org/10.1182/blood-2023-181351
Published: 2023
Journal Articles

Improved Outcomes of All-Trans-Retinoic Acid and Arsenic Trioxide Plus Idarubicin As a Frontline Treatment in Adult Patients with Acute Promyelocytic Leukemia

Shiwei Yang, Zunmin Zhu, Xiaojian Zhu, Yicheng Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 5088.
https://doi.org/10.1182/blood-2019-128602
Published: 2019
Journal Articles

The Interaction of Tumor Cells and Myeloid-Derived Suppressor Cells in Chronic Myelogenous Leukemia

Hui Xu, Zunmin Zhu, Xiaojian Zhu, Na Shen, Shu Zhou, Yicheng Zhang
Journal: Blood
Blood (2019) 134 (Supplement_1): 1636.
https://doi.org/10.1182/blood-2019-125563
Published: 2019
Journal Articles

Retrospective Analysis of Chinese Chronic Myeloid Leukemia Patients Who Have Stopped Tyrosine Kinase Inhibitors

Xiaojian Zhu, Yong You, PhD, Yicheng Zhang, MD PhD, Minghui Duan, MD, Yu Zhu, MD PhD, Bingcheng Liu, MD, Xin Du, MD, Suning Chen, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5443.
https://doi.org/10.1182/blood-2018-99-113854
Published: 2018
Journal Articles

Role of Folate Receptor 3 in Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia

Na Shen, Xiaojian Zhu, Shu Zhou, Yong You, PhD, Zhaodong Zhong, PhD, Xiaoying Zhu, Qing Li, PhD, Ping Zou, PhD, Yicheng Zhang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2998.
https://doi.org/10.1182/blood-2018-99-111611
Published: 2018
Journal Articles

Correlation of Altered Expression of RIZ1 to Diagnosis, Risk Stratification, and Disease Progression in 56 Acute Leukemia Patients.

Qiubai Li, MD, Xiaojian Zhu, MD, Xiaoqing Li, PhD, Xiangjun Chen, Yong You, MD, Shi Huang, Shiang Huang, MD, Ping Zou, MD, Zhichao Chen
Journal: Blood
Blood (2009) 114 (22): 2627.
https://doi.org/10.1182/blood.V114.22.2627.2627
Published: 2009